Liposome (Lipodine™)-mediated DNA vaccination by the oral route

Yvonne Perrie*, Mia Obrenovic, David McCarthy, Gregory Gregoriadis

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Plasmid DNA pRc/CMV HBS encoding the S (small) region of hepatitis B surface antigen (HBsAg) was incorporated by the dehydration-rehydration method into Lipodine™ liposomes composed of 16 μmoles phosphatidylcholine (PC) or distearoyl phosphatidylcholine (DSPC), 8 μmoles of (dioleoyl phosphatidylethanolamine (DOPE) or cholesterol and 4 μmoles of the cationic lipid 1,2-dioleoyl-3-(trimethylammonium propane (DOTAP) (molar ratios 1:0.5:0.25). Incorporation efficiency was high (89-93% of the amount of DNA used) in all four formulations tested and incorporated DNA was shown to be resistant to displacement in the presence of the competing anionic sodium dodecyl sulphate molecules. This is consistent with the notion that most of the DNA is incorporated within the multilamellar vesicles structure rather than being vesicle surface-complexed. Stability studies performed in simulated intestinal media also demonstrated that dehydration-rehydration vesicles (DRV) incorporating DNA (DRV(DNA)) were able to retain significantly more of their DNA content compared to DNA complexed with preformed small unilamellar vesicles (SUV-DNA) of the same composition. Moreover, after 4h incubation in the media, DNA loss for DSPC DRV(DNA) was only minimal, suggesting this to be the most stable formulation. Oral (intragastric) liposome-mediated DNA immunisation studies employing a variety of DRV(DNA) formulations as well as naked DNA revealed that secreted IgA responses against the encoded HBsAg were (as early as three weeks after the first dose) substantially higher after dosing with 100 μg liposome-entrapped DNA compared to naked DNA. Throughout the fourteen week investigation, IgA responses in mice were consistently higher with the DSPC DRV(DNA) liposomes compared to naked DNA and correlated well with their improved DNA retention when exposed to model intestinal fluids. To investigate gene expression after oral (intragastric) administration, mice were given 100 μg of naked or DSPC DRV liposome-entrapped plasmid DNA expressing the enhanced green fluorescent protein (pCMV.EGFP). Expression of the gene, in terms of fluorescence intensity in the draining mesenteric lymph nodes, was much greater in mice dosed with liposomal DNA than in animals dosed with the naked DNA. These results suggest that DSPC DRV liposomes containing DNA (Lipodine™) may be a useful system for the oral delivery of DNA vaccines.

Original languageEnglish
Pages (from-to)185-197
Number of pages13
JournalJournal of Liposome Research
Volume12
Issue number1-2
DOIs
Publication statusPublished - 15 Aug 2002
Event5th International Conference on Liposome Advances - London, United Kingdom
Duration: 17 Dec 200121 Dec 2001

Fingerprint Dive into the research topics of 'Liposome (Lipodine™)-mediated DNA vaccination by the oral route'. Together they form a unique fingerprint.

  • Cite this

    Perrie, Y., Obrenovic, M., McCarthy, D., & Gregoriadis, G. (2002). Liposome (Lipodine™)-mediated DNA vaccination by the oral route. Journal of Liposome Research, 12(1-2), 185-197. https://doi.org/10.1081/LPR-120004792